Improved targeting of an anti-TAG-72 antibody drug conjugate for the treatment of ovarian cancer.
Megan MinnixLin LiPaul YazakiJunie CheaErasmus PokuDavid ColcherJohn E ShivelyPublished in: Cancer medicine (2020)
We conclude that CC49-Br-MMAE with a high DAR and stable linker performs well in a difficult to treat solid tumor model.
Keyphrases